GC2402 Study Site 103 — Port Charlotte, Florida

GC2402 Study Site 103 is a clinical research site located in Port Charlotte, Florida, United States 33952.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

GC2402 Study Site 103 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy).

Sponsors: Grifols Therapeutics LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Port Charlotte

Browse all research sites in Florida · View every site in Port Charlotte

• Fawcett Memorial Hospital
• University of Miami
• BonSecours - St. Joseph's Hospital
• Research Site
• MEDSOL Clinical Research Center
• Neurostudies Inc
• Peace River Cardiovascular Center
• Novartis Investigative Site
• Hanson Clinical Research Center
• Florida Cancer Specialists
• GSK Investigational Site
• Charlotte Heart Group Research Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GC2402 Study Site 103?

GC2402 Study Site 103 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GC2402 Study Site 103 conducted?

GC2402 Study Site 103 has 1 clinical trials on record, with 1 currently active. Their work covers CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy).

Is GC2402 Study Site 103 accredited by Crixeo Clinical Trials?

GC2402 Study Site 103 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GC2402 Study Site 103?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.